T细胞的耗尽启动了三级淋巴体结构,并激活了癌症免疫循环
Wen-Ping Lin1, Hao Li2, Zhi-Jun Sun2
1State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Frontier Science Center for Immunology and Metabolism, Taikang Center for Life and Medical Sciences, Wuhan University, Wuhan 430079, PR China.
EBioMedicine
|May 15, 2024
概括
消耗T细胞阻碍免疫检查点阻断 (ICB) 癌症治疗. 本综述探讨了如何利用T细胞枯竭来重振抗瘤免疫力并改善患者的治疗结果.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 癌症研究 癌症研究
背景情况:
- 免疫检查点封锁 (ICB) 已经彻底改变了癌症治疗.
- T细胞耗尽,T细胞功能障碍的状态,限制了ICB的疗效.
- 三级淋巴体结构 (TLS) 与T细胞耗尽和抗瘤免疫有关.
研究的目的:
- 探索T细胞耗尽在癌症免疫力中的作用.
- 了解T细胞枯竭和三级淋巴体结构 (TLS) 之间的联系.
- 总结免疫治疗策略来增强ICB反应.
主要方法:
- 关于T细胞耗尽和三级淋巴体结构 (TLS) 的文献综述.
- 在T细胞耗尽的背景下分析癌症免疫 (CI) 周期.
- 新兴免疫治疗方法的综合.
主要成果:
- T细胞耗尽是影响ICB治疗有效性的关键因素.
- 消耗T细胞可以作为一个信号机制来增强抗瘤免疫力.
- TLS的形成与T细胞耗尽和抗瘤反应相关.
结论:
- 利用T细胞疲劳对于克服ICB抵抗至关重要.
- 准T细胞枯竭和TLS可能会改善癌症免疫治疗中的患者预后.
- 新的策略正在出现,以增强癌症免疫 (CI) 周期和ICB疗效.
相关概念视频
01:22T Cell Activation and Clonal Selection
709
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
709
01:24T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K
01:27Tumor Immunotherapy
518
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
518
01:27Cytotoxic T Cells-mediated Immune Response
901
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
901
01:23Cells of the Adaptive Immune Response
980
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
980
01:40Cell-mediated Immune Responses
68.2K
Overview
68.2K